跳至主要内容
临床试验/IRCT201504211475N7
IRCT201504211475N7已完成3 期

Randomized, double blind, clinical trial on efficacy of topical nano-liposomal amphotericin B for the treatment of anthroponotic cutaneous leishmaniasis (ACL) caused by Leishmania tropica (Phase 3)

MoH, EMRO/WHO0 个研究点目标入组 120 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
120

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
12 years 至 60 years(—)
性别
All

入选标准

  • Male or female aged between 12 to 60 years.
  • Parasitologically proven CL due to L. tropica.
  • In general good health based on history and physical examination.
  • Number of lesion at most 5.
  • Lesion size less than 3 cm.
  • Signed informed consent voluntarily and knowingly**. ** Guardian’s signature for volunteer less than 18 years old.
  • Exclusion criteria:
  • lactating women
  • Use of other types of treatment for CL.
  • Involvement in any other drug or vaccine trial during the study period.
  • Known heart, kidney, liver diseases based on history and physical exam.

排除标准

  • 未提供

研究者

发起方
MoH, EMRO/WHO

相似试验

Clinical trial of efficacy of combination of topical... | 临床试验